Bioorganic chemistry

Environmental science and pollution research international

Carbohydrate polymers

Journal of hazardous materials

turkish journal of chemistry

environmental toxicology

[1] Determination of N-acetylcysteine in the presence of ciprofloxacin or levofloxacin in microparticulate dry powder inhalers

[2] Embryonic development, locomotor behavior, biochemical, and epigenetic effects of the pharmaceutical drugs paracetamol and ciprofloxacin in larvae and embryos of Danio rerio when exposed to environmental realistic levels of both drugs.

[3] Prepartion and application of novel blast furnace dust based catalytic-ceramic-filler in electrolysis assisted catalytic micro-electrolysis system for ciprofloxacin wastewater treatment.

[4] Design, synthesis and molecular docking of new N-4-piperazinyl ciprofloxacin-triazole hybrids with potential antimicrobial activity.

[5] pharmacokinetic profile of enrofloxacin and its metabolite ciprofloxacin in asian house geckos (hemidactylus frenatus) after single-dose oral administration of enrofloxacin

[6] prescripción de ciprofloxacino por vía parenteral en pacientes ingresados en los servicios de medicina interna y caumatología de un hospital general

[7] an evaluation of the antimicrobial synergy of garlic (allium sativum) and utazi (gongronema latifolium) on escherichia coli and staphylococcus aureus

[8] role of 5´-amp-activated protein kinase activators in regulating nuclear factor kappa b signaling

[9] ciprofloxacin induced bullous fixed drug reaction: three case reports

[10] clinical resistance of staphylococcus keratitis to ciprofloxacin monotherapy.

[11] synthesis, crystal structure, stacking effect and antibacterial studies of a novel quaternary copper (ii) complex with quinolone

[12] oral manifestations of hiv

[13] comparison of the effect of co-trimoxazole and co-trimoxazole plus ciprofloxacin in urinary tract infection prophylaxis in kidney transplant patients

[14] Evolution and transmission of a conjugative plasmid encoding both ciprofloxacin and ceftriaxone resistance in Salmonella.

[15] Synthesis, identification and application of the novel metal-organic framework Fe<inf>3</inf>O<inf>4</inf>@PAA@ZIF-8 for the drug delivery of ciprofloxacin and investigation of antibacterial activity

[16] Determination of N-acetylcysteine in the presence of ciprofloxacin or levofloxacin in microparticulate dry powder inhalers

[17] Expansion of Salmonella Typhi clonal lineages with ampicillin resistance and reduced ciprofloxacin susceptibility in Eastern China

[18] In vitro and in vivo activity of ciprofloxacin/fosfomycin combination therapy against ciprofloxacin-resistant Shigella flexneri isolates

[19] Mutations in gyrB play an important role in ciprofloxacin-resistant Pseudomonas aeruginosa

[20] The clinical significance of silent mutations with respect to ciprofloxacin resistance in MRSA

[21] Expansion of Salmonella Typhi clonal lineages with ampicillin resistance and reduced ciprofloxacin susceptibility in Eastern China

[22] In vitro and in vivo activity of ciprofloxacin/fosfomycin combination therapy against ciprofloxacin-resistant Shigella flexneri isolates

[23] Expansion of Salmonella Typhi clonal lineages with ampicillin resistance and reduced ciprofloxacin susceptibility in Eastern China

[24] In vitro and in vivo activity of ciprofloxacin/fosfomycin combination therapy against ciprofloxacin-resistant Shigella flexneri isolates

[25] Mutations in gyrB play an important role in ciprofloxacin-resistant Pseudomonas aeruginosa

[26] The clinical significance of silent mutations with respect to ciprofloxacin resistance in MRSA

[27] Determination of N-acetylcysteine in the presence of ciprofloxacin or levofloxacin in microparticulate dry powder inhalers

[28] Ecotoxicological effects and accumulation of ciprofloxacin in Eichhornia crassipes under hydroponic conditions.

[29] Effects of green synthesis, magnetization, and regeneration on ciprofloxacin removal by bimetallic nZVI/Cu composites and insights of degradation mechanism.

[30] Experimental and theoretical aspects of biochar-supported nanoscale zero-valent iron activating H<inf>2</inf>O<inf>2</inf> for ciprofloxacin removal from aqueous solution

[31] Ultrathin BiOCl/nitrogen-doped graphene quantum dots composites with strong adsorption and effective photocatalytic activity for the degradation of antibiotic ciprofloxacin

[32] The BiOCl/diatomite composites for rapid photocatalytic degradation of ciprofloxacin: Efficiency, toxicity evaluation, mechanisms and pathways

[33] Facile synthesis of ZnFeO@RGO nanocomposites towards photocatalytic ciprofloxacin degradation and H energy production.

[34] Synthesis, identification and application of the novel metal-organic framework Fe<inf>3</inf>O<inf>4</inf>@PAA@ZIF-8 for the drug delivery of ciprofloxacin and investigation of antibacterial activity

[35] Embryonic development, locomotor behavior, biochemical, and epigenetic effects of the pharmaceutical drugs paracetamol and ciprofloxacin in larvae and embryos of Danio rerio when exposed to environmental realistic levels of both drugs.

[36] Ciprofloxacin-1,2,3-triazole-isatin hybrids tethered via amide: Design, synthesis, and in vitro anti-mycobacterial activity evaluation

[37] Prepartion and application of novel blast furnace dust based catalytic-ceramic-filler in electrolysis assisted catalytic micro-electrolysis system for ciprofloxacin wastewater treatment.

[38] Ciprofloxacin/Gatifloxacin-1,2,3-triazole-isatin Hybrids and Their In Vitro Anticancer Activity

[39] Design, synthesis and molecular docking of new N-4-piperazinyl ciprofloxacin-triazole hybrids with potential antimicrobial activity.

[40] Design, synthesis and antibacterial evaluation of 1-[(1R,2S)-2-Fluorocyclopropyl] Ciprofloxacin-(4-Methyl-3-Aryl)-1,2,4-Triazole-5(4H)-Thione Hybrids

[41] Design, Synthesis and Antibacterial Evaluation of 1-[(1R,2S)-2-Fluorocyclopropyl]ciprofloxacin-1,2,4-triazole-5(4H)-thione Hybrids

[42] Persulfate activation by sulfide-modified nanoscale iron supported by biochar (S-nZVI/BC) for degradation of ciprofloxacin

[43] New matrix certified reference material for accurate measurement of ciprofloxacin residue in egg.

[44] Porous-CdS/Cu<inf>2</inf>O/graphitic-C<inf>3</inf>N<inf>4</inf> dual p-n junctions as highly efficient photo/catalysts for degrading ciprofloxacin and generating hydrogen using solar energy

[45] Ciprofloxacin-Resistant Serovar Kentucky ST198 in Broiler Chicken Supply Chain and Patients, China, 2010-2016.

[46] Photo-induced degradation of bio-toxic Ciprofloxacin using the porous 3D hybrid architecture of an atomically thin sulfur-doped g-CN/ZnO nanosheet.

[47] Azithromycin and ciprofloxacin have a chloroquine-like effect on respiratory epithelial cells.

[48] Outbreak of coagulase negative staphylococcus highly resistant to ciprofloxacin in a leukaemia unit

[49] Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

[50] Effect of Delaying Treatment on Efficacy of Ciprofloxacin and Levofloxacin in the African Green Monkey Model of Pneumonic Plague

[51] Development of ciprofloxacin and nano-hydroxyapatite dual-loaded polyurethane scaffolds for simultaneous treatment of bone defects and osteomyelitis

[52] Comparative activities of cefuroxime, amoxicillin-clavulanic acid, ciprofloxacin, enoxacin, and ofloxacin against aerobic and anaerobic bacteria isolated from bite wounds

[53] Ciprofloxacin for the Treatment of Uncomplicated Gonorrhea Infection in Adolescents: Does the Benefit Outweigh the Risk?

[54] Comparative activities of cefuroxime, amoxicillin-clavulanic acid, ciprofloxacin, enoxacin, and ofloxacin against aerobic and anaerobic bacteria isolated from bite wounds.

[55] Ciprofloxacin-loaded bioadhesive hydrogels for ocular applications

[56] Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients.

[57] Comparative in vitro activity of gemifloxacin, ciprofloxacin, levofloxacin and ofloxacin in a North American surveillance study

[58] Investigation into the selection frequency of resistant mutants and the bacterial kill rate by levofloxacin and ciprofloxacin in non-mucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients

[59] Pharmacodynamics of levofloxacin and ciprofloxacin in a murine pneumonia model: peak concentration/MIC versus area under the curve/MIC ratios

[60] Apparent failure of moxifloxacin to prevent ciprofloxacin- and levofloxacin-susceptible Pseudomonas aeruginosa bacteremia in neutropenic patients undergoing peripheral blood stem cell transplantation

[61] pharmacokinetic profile of enrofloxacin and its metabolite ciprofloxacin in asian house geckos (hemidactylus frenatus) after single-dose oral administration of enrofloxacin

[62] prescripción de ciprofloxacino por vía parenteral en pacientes ingresados en los servicios de medicina interna y caumatología de un hospital general

[63] ciprofloxacin induced bullous fixed drug reaction: three case reports

[64] Structural elucidation of Levofloxacin and Ciprofloxacin using density functional theory and Raman spectroscopy with inexpensive lab-built setup

[65] association between mutations in gyra and parc genes of acinetobacter baumannii clinical isolates and ciprofloxacin resistance

[66] the study of synergistic effects of n.butanolic cyclamen coum extract and ciprofloxacin on inhibition of pseudomonas aeruginosa biofilm formation

[67] clinical resistance of staphylococcus keratitis to ciprofloxacin monotherapy.

[68] herb-drug interaction: effects of relinqing® granule on the pharmacokinetics of ciprofloxacin, sulfamethoxazole, and trimethoprim in rats

[69] escherichia coli resistente a ciprofloxacina em pacientes internados em hospital universitário de manaus, 2015

[70] severe rhabdomyolysis associated with simvastatin and role of ciprofloxacin and amlodipine coadministration

[71] spectroscopy and speciation studies on the interactions of aluminum (iii) with ciprofloxacin and β-nicotinamide adenine dinucleotide phosphate in aqueous solutions

[72] comparison of the effect of co-trimoxazole and co-trimoxazole plus ciprofloxacin in urinary tract infection prophylaxis in kidney transplant patients

[73] transcriptome profiling reveals interplay of multifaceted stress response in escherichia coli on exposure to glutathione and ciprofloxacin

[74] ciprofloxacin controlled-solid lipid nanoparticles: characterization, in vitro release, and antibacterial activity assessment

[75] Occurrence of Ceftriaxone Resistance in Ciprofloxacin-Resistant Salmonella enterica Serotype Choleraesuis Isolates Causing Recurrent Infection

[76] High Prevalence of Ciprofloxacin-Resistant Neisseria gonorrhoeae in Northern Taiwan

[77] A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group

[78] Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial

[79] Similarity between human and chicken Escherichia coli isolates in relation to ciprofloxacin resistance status

[80] Comparison of Ciprofloxacin (7 Days) and Trimethoprim-Sulfamethoxazole (14 Days) for Acute Uncomplicated Pyelonephritis in Women: A Randomized Trial